Jarosław Baran

5.2k citations
110 papers · 4.0k indexed · 1 hit paper · h-index 27

Jarosław Baran

106 papers receiving 3.9k citations

Hit Papers

The Methods of Choice for Extracellular Vesicles (EVs) Ch...4162017202620202023100200300400

Peers

Jarosław Baran
Comparison fields: 5 of 136
  • Cancer Research 925
  • Immunology 1.2k
  • Molecular Biology 1.9k
  • Hematology 229
  • Immunology and Allergy 124
Replace Qing Zhang with:
Qing Zhang China
Xiaoming Sun China
Sandra Liekens Belgium
Hua Tang China
Yong Dai China
Nataša Obermajer Slovenia
Bård Smedsrød Norway
Peter Panizzi United States
Chunhong Ma China
Martin Leverkus Germany
Jarosław Baran relative to Qing Zhang China Qing Zhang's profile →
Citations per field
00.5×1.5×
Qing Zhang · 1×
Citations per year

Countries citing papers authored by Jarosław Baran

Since Specialization
Citations

This map shows the geographic impact of Jarosław Baran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarosław Baran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarosław Baran more than expected).

Fields of papers citing papers by Jarosław Baran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarosław Baran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarosław Baran. The network helps show where Jarosław Baran may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jarosław Baran, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jarosław Baran Line = papers co-authored together Jarosław Baran links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20231
2 20225
3 202117
4 20211
5 202017
6 202018
7 202012
8 20198
9 201911
10 20198
11 20184
12 201818
13 2015220
14 20124
15 201114
16 2009216
17 20093
18 2004407
19
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
2003149
20 200073

About Jarosław Baran

Jarosław Baran is a scholar working on Immunology, Hematology and Oncology, having authored 110 papers that have together received 4.0k indexed citations. Recurring topics across this work include Immune cells in cancer (25 papers), Immune Cell Function and Interaction (21 papers), Extracellular vesicles in disease (15 papers), Nanoplatforms for cancer theranostics (12 papers), Gold and Silver Nanoparticles Synthesis and Applications (10 papers), Immunotherapy and Immune Responses (10 papers), Immune Response and Inflammation (10 papers) and RNA Interference and Gene Delivery (7 papers). The work is most often cited by research in Cancer Research (925 citations), Immunology (1.2k citations) and Molecular Biology (1.9k citations). Jarosław Baran has collaborated with scholars based in Poland, United States and Germany. Frequent co-authors include Monika Baj‐Krzyworzeka, Rafał Szatanek, Maciej Siedlar, Marek Zembala, Kazimierz Węglarczyk, Daniel J. Allendorf, Gordon D. Ross, Joanna Depciuch, Mariusz Z. Ratajczak and Jun Yan.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026